Table G-1Example of a patient with an ACR 50 response to treatment

Outcomes MeasuredBaselineEndpoint
Tender joints count *126
Swollen joints count *83
Patient’s pain score*6020
Patient’s physical function (disability) score8060
Physician’s global activity score*5020
C-reactive protein*3.61.4
*

At least 50 percent improvement between baseline and endpoint measurements.

At least 50 percent improvement between baseline and endpoint measurements.

From: Appendix G, Clinical and Self-Reported Scales and Instruments Commonly Used in Studies of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis

Cover of Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report
Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report [Internet].
Comparative Effectiveness Reviews, No. 54.
Donahue KE, Jonas D, Hansen RA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.